CRYSTAL BROWN: Open Payments
NPI 1063494045 · MOUNT VERNON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 37 payments from 11 companies in 2025. Trend: 2023 $1,211 · 2024 $674 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $264 |
| Novo Nordisk Inc | 5 | $78 |
| Lundbeck LLC | 3 | $61 |
| Lilly USA, LLC | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| PFIZER INC. | 1 | $31 |
| MILLICENT US INC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
Products named: VRAYLAR, VYEPTI, QULIPTA, MOUNJARO, Ozempic, CAPLYTA, NURTEC ODT, Rybelsus.
Industry payments across KY — which companies pay providers there.
